Merck Serono News
Most Popular Merck Serono Story
Merck Serono, Theratechnologies ink $215M deal
Merck Serono has signed a deal to license the U.S. commercialization right to tesamorelin, a drug to treat excess abdominal fat in HIV patients with lipodystrophy. Theratechnologies retains rights to... Read more...
Latest Headlines
- May 12, 2009
- March 23, 2009
- January 13, 2009
- October 29, 2008
- September 4, 2008
- June 18, 2008
- August 30, 2007
- August 29, 2007
- August 24, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




